Madison Air Solutions (MAIR) is initiated with a buy rating due to strong structural demand for mission-critical air solutions beyond traditional HVAC cycles. Its Commercial segment benefits from AI-driven data center growth, with Q1 2026 organic sales up 17.2% and backlog increasing 125% year-over-year. The recent AprilAire acquisition enhances its Residential portfolio, aiming for higher revenue per job and less reliance on equipment replacement cycles. Valued at 23x EBITDA, the stock offers about 60% upside if MAIR achieves $1.59 billion adjusted EBITDA by fiscal year 2029, though risks include backlog conversion speed and softness in the Residential segment.
The global reactive hot melt adhesives market is projected to grow from $2.02 billion in 2025 to $4.29 billion by 2035, at a CAGR of 7.72%. Growth is driven by regulations limiting solvent-based adhesives, increased use of polyurethane adhesives in a...
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
CHARBONE Corporation has increased its helium delivery fleet from one to five units to meet rising demand caused by global helium supply disruptions, notably from Qatar. This expansion supports North American customers in sectors like semiconductors ...
Citi has started coverage of Hikma Pharmaceuticals with a 'buy' rating and a £17 price target, highlighting the company's strategic shift towards differentiated products and US manufacturing investments. The broker sees a 14% potential share price re...
Xenon Pharmaceuticals is evolving into a late-stage, cash-rich neuroscience company with a validated Kv7 potassium channel platform. Its lead drug candidate, azetukalner, has shown strong effectiveness in treating refractory focal onset seizures and ...
